NCT01838070View on ClinicalTrials.gov

Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)

CompletedOBSERVATIONAL

Enrollment

614

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

May 31, 2016

Conditions

Hepatitis A

Trial Locations (1)

120 752

Seoul

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01838070 - Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U) | Biotech Hunter | Biotech Hunter